In-licensing opportunities

partneringVernalis has distinctive abilities in oncology, pain therapeutics and diseases of the central nervous system. We are actively interested in in-licensing candidates in these areas at pre-clinical and early clinical stages of development.

Licensing programmes to Vernalis gives you access to our world-class research and development expertise, and, for many companies, will represent the most efficient and economical route to completing the essential early stages of drug development.

Please contact us for further details. Get in touch >

Latest News

Wednesday, 02 May 2012

Successful Outcome for V81444 in Phase I Study

Vernalis today announces the successful outcome of its Phase I trial of V81444